Abstract
Many members of the nuclear receptor (NR) superfamily are expressed in the skin making them a highly interesting subject of dermato-endocrine research. Natural and synthetic NR ligands are used for the treatment of various skin disorders. We discuss here the impact of the dynamic nature of chromatin organization, i.e., the spatio-temporal changes of chromatin region of NR target genes. This dynamics is triggered by environmental changes, of which for NRs the exposure with their ligands is most critical. For an understanding of skin disorders, which involve the actions of NRs, this means that the parameter time should be carefully considered in context of other factors that may influence the chromatin organization, and by this the responsiveness, of key NR target genes.
Key words: transcription, nuclear receptor, chromatin, dynamics, skin
Nuclear Receptors in the Skin
Nuclear receptors (NRs) form a structurally-related superfamily of transcription factors (TFs) that are involved in the regulation of nearly all biological processes, of which the control of metabolism, of cellular growth and differentiation and of inflammation, may be the most important.1 The NR superfamily contains 48 human members, half of which are activated by small lipophilic ligands. These ligands are either classical endocrine hormones, such as cortisol, retinoids and 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] or dietary lipids, such as polyunsaturated fatty acids and oxysterols.2 This makes NRs interesting pharmacological targets for nearly every human tissue and its diseases.
Many members of the NR superfamily, such as the glucocorticoid receptor (GR), retinoic acid receptor (RAR) γ, vitamin D receptor (VDR), peroxisome-proliferator-activated receptor (PPAR) δ and liver X receptors (LXR) β, are expressed in the different cells of the skin, such as keratinocytes, dermal fibroblasts and infiltrating immune cells (phagocytes, dendritic cells and T lymphocytes).3–9 This makes theses receptors a highly interesting subjects of dermato-endocrine research and their natural ligands as well as their synthetic derivatives targets for the treatment of various common skin disorders, such as psoriasis [where cortisol and synthetic 1,25(OH)2D3 derivatives are very effective] and acne (which is often treated with RAR ligands), of photoaging and chronological aging of the skin and even of skin cancer.9 Core processes in there are inflammation and disturbed differentiation, which both can be modulated by NRs and their ligands. Interestingly, skin is the place of the synthesis of vitamin D3 and posses the enzymatic machinery to locally produce 1,25(OH)2D3.4,10
Based on their affinity to ligands the members of the NR superfamily can be sorted into three subgroups: (1) classical endocrine receptors that bind their ligands with a Kd of 1 nM or less and that respond rapidly to hormonal stimulus, (2) adopted orphans that bind dietary lipids and xenobiotics with far lower affinity, i.e., a Kd in the range of µM to mM11 and (3) orphans that do not have any known, natural ligands and behave like regular TFs. Alternatively, the NR superfamily can be divided to sequence homology into seven classes12 or based on their dimerization and DNA-binding properties into four subgroups.13
NRs regulate gene expression via specific DNA sequences called response elements (REs) that locate within regulatory regions of the target genes and to which NRs bind as homo- or heterodimers.14 Consequently, most REs are formed by two recognition motifs, whose relative distance and orientation define, which NRs can associate with a given RE. Recently published genome-wide chromatin immunoprecipitation (ChIP)-Seq studies suggest that with a given human tissue the genome contains 2,000 to 10,000 binding sites per NR.15,16 However, microarrays from the same tissues in average demonstrated only some 200 to 1,000 genes to be direct target of the given NRs, i.e., there seem to be some ten-fold more genomic NR binding sites than primary target genes.16,17 Interestingly, most of these sites do not locate within classical promoter regions, but within introns and more distal regions,18 a characteristic that appears to be common for most NRs.19 These genome-wide data suggest that in average a given primary NR target gene is regulated by multiple binding sites of the NR at various positions relative to its transcription start site (TSS). This confirms the data obtained from single gene studies, where multiple functional REs per gene were described.20–23 Moreover, the spatial organization of the NR binding sites appears to have a critical role in bringing via DNA looping at least one activated NR protein close to the TSS of the respective primary NR target gene.
Co-Regulator Proteins
For their effective function in gene activation and repression NR proteins have to interact with a number of co-regulatory proteins, which function either as co-activators (CoAs) 24 or as co-repressors (CoRs).25 In the absence of ligand NR can form complexes with CoR proteins, which in turn associate with histone deacetylases (HDACs) leading to a local condensation of chromatin.26 The classical model of NR signaling suggests that ligand binding induces a conformational change within the ligand-binding domain of the NR leading to dissociation of CoRs and formation of interaction surface for CoAs.27 Some CoAs have histone acetyltransferase (HAT) activity or they recruit other CoAs possessing such activity. The action of these enzymes modulates the condensation status of chromatin leading to local chromatin relaxation.28 Subsequently, NRs interact with CoAs that are members of the mediator complex. This connects the NR binding chromatin region to the basal transcriptional machinery assembled on the TSS of the target gene.29 Thus, ligand-activated NRs serve as adaptors between the regulatory genomic region and chromatin modifying enzyme complexes as well as activators of RNA polymerase II.
However, the switch between gene repression and activation is more complex than a simple alternative recruitment of two different regulatory complexes.30 Most co-regulators are co-expressed in the same cell type at relatively similar levels, which raises the possibility of their concomitant recruitment to a specific promoter. Moreover, it is presently not clear, whether co-regulators already mark in some cases active regulatory elements independent of DNA-binding TFs or if they always require active recruitment to target sites. Both aspects emphasize that the spatio-temporal context, i.e., the nuclear organization and the timing of the association of TFs and their co-regulators, plays an important role in controlling gene transcription.
Impact of Histone Modifications, Histone Variants and Chromatin Remodeling
In the eukaryotic cell, genomic DNA is by default tightly packed with nucleosome-forming histone proteins, i.e., in a non-accessible repressive status.31,32 Therefore, the pre-requisite for the expression of genes within a given genomic region is the local relaxation of these chromatin proteins, in order to allow TFs to associate with their cognate binding sites within promoter and enhancer regions. Mechanisms to modify chromatin structure include covalent post-translational histone modifications, replacement of the standard histones with histone variants and nucleosome remodeling.33,34
Histone acetylation.
Histone acetylation catalyzed by HATs is strongly associated with transcriptional activation.35 For example, a genome-wide analysis of di-acetylated histone H3K9 and H3K14 in resting and activated human T-cells revealed that chromatin accessibility of a genetic locus is increased by hyper-acetylation of a limited number of regulatory elements, i.e., promoters and enhancers.36 Acetylated histone tails can also bind chromatin remodelers that have bromodomain binding modules.33,37 Lysine acetylation is assumed to neutralize the positive charges of the N-terminal histone tails thus weakening the histone-DNA interactions.38 Alternatively, the lysine acetylation may cause a conformational change within the nucleosomes that leads to destabilization of DNA-nucleosome arrangement.39
Histone methylation.
Histone methylation may have an even more critical role for transcriptional regulation than histone acetylation, since depending on the amino acid residue within the histone tails to be modified, the effect may be either activating or repressive. Since the addition of a relatively small methyl group is not enough to neutralize the positive charge of lysine or arginine residues,40 histone methylation rather creates binding sites for regulatory proteins having chromodomain binding modules, which can either condense or relax the chromatin structure.37 The methylations of histones H3K4, H3K36, H3K79, and H2BK541,42 are associated with transcriptional activation, whereas methylations of histones H3K9, H3K27 and H4K20 are related to inactive chromatin.43 Importantly, the N-terminal histone tails can be methylated to multiple sites. The lysine residues may be mono-, di- or tri-methylated and arginine residues mono- or di-methylated41 and the level of methylation appears to be a specific landmark for different genomic loci. For example, tri-methylated H3K4 is found at the beginning, di-methylated H3K4 in the middle and mono-methylated H3K4 near the 3′ ends of actively transcribed genes.44 Furthermore, tri-methylated H3K36 is enriched within the coding regions and tri-methylated H3K79 throughout the transcribed regions. Mono-methylated H3K27 is distributed throughout euchromatin, but selectively removed from the start sites of active genes, suggesting that removal of the above histone mark may be a prerequisite for transcription initiation.
Histone variants.
All of the four canonical histones have variants, of which H2A.Z and H3.3 are associated with transcription.45 H3.3 is related to transcriptionally active genomic loci throughout the cell cycle.46 H2A.Z is suggested to have two functions. It maintains the transcription when associated with promoters and, on the other hand, it represses the transcription when associated with the coding regions.42,47 The different effects depend on the other histones that form the histone octamer together with H2A.Z. The combination of H2A.Z and H3.3 provides an unusually labile chromatin conformation, whereas H2A.Z and H3 form more stable nucleosomes.48 H2A.Z is also highly enriched at insulator sites that separate functional chromatin regions from each other.42 The benefit of using histone variants might lie in a rapid requirement of changing the chromatin environment into a more active or repressed state.
Chromatin remodeling.
In addition to the post-translational histone modifications, transcriptional activation often requires remodeling of nucleosomes within the regulative regions and the TSS of a gene to be activated. This is achieved via function of specific ATP-dependent chromatin remodeling complexes.49–51 However, continuous presence of chromatin remodelers is not required for maintenance of nucleosome repositioning.52 All eukaryotes have at least five families of chromatin remodelers (SWI/SNF, ISWI, NURD/Mi-2/CHD, INO80 and SWR1), all of which are related to transcriptional regulation among many other functions.33 The most widely studied family in mammalian cells is SWI/SNF, which contains either BRG1 or BRM as an ATPase subunit along with several BRG-associated factors. Chromatin remodeling by SWI/SNF appears not to be necessary for the activation of primary responding genes.53 Consistently, most of these genes have high basal levels of tri-methylated H3K4 and acetylated H3K9.54 Secondary responding genes need to be acetylated before chromatin remodeling, since histone acetylation has been observed to be a pre-requisite for the function of the SWI/SNF complex.52 Indeed, SWI/SNF ATPases contain bromodomains that bind to acetylated histone tails.33 The presence of active chromatin markers at the regulatory regions of SWI/SNF-independent primary response genes is dependent on the GC-content of the DNA sequence.55 These CpG islands are associated with a low nucleosome density and are present at 72% of the mammalian promoters.56 In addition, GC-rich primary responding genes are characterized by the presence of CoR complexes, such as NCoR/HDAC3 and CoREST/HDAC1, which may counteract the activity of chromatin while in basal state.54
Dynamics of Transcriptional Regulation
In higher eukaryotes successful regulation of gene expression in response to environmental cues requires the co-operation of three kinds of regulatory DNA elements: core promoters contain the TSS, proximal regulatory regions and enhancers.57 Recently, several studies have suggested that mRNA transcription is a highly dynamic process, in which TFs cyclically associate with regulatory chromatin regions.21–23,58 In some cases, the cycling of TFs appears to mirror to the mRNA expression level of regulated genes.
To regulate the target gene, the enhancer must physically contact the core promoter by looping out the intervening chromatin.59,60 Recent studies have suggested that during transcription the distant enhancers do not simply connect with the promoter via static chromatin looping, but this chromatin looping appears to be a highly dynamic process, in which the loops form and release with the same periodicity as cycling of TFs at the enhancer regions.21,22 Thus, chromatin loops form between distant enhancers and TSS regions in average with a periodicity of 40–60 min, suggesting that the looping cannot be a random process, but it must be somehow controlled.
Presently, the exact mechanism behind chromatin looping is not known and needs to be clarified. It has been proposed that TFs associated with enhancers interact directly with protein bound to the TSS or that the TF complex migrates along the chromatin fiber until it reaches the TSS region. Another suggestion is that DNA sequences next to enhancer and promoter regions recruit proteins that are not needed in transcriptional regulation per se, but are responsible for chromatin loop formation.61,62 Interestingly, when transcription is initiated, the promoter and the 3′-end of the gene interact to form a looped gene conformation.63 This loop is maintained as a memory gene loop (MGL) for up to 1 h during intervening periods of transcriptional repression and is required for faster RNA polymerase II recruitment upon re-induction. Consequently, the transcription rate is possibly controlled both by MGL formation and TF cycling. Even inter-chromosomal interactions have been observed. Spilianakis and co-workers reported that the interferon (IFN)γ gene and a multi-gene complex encoding interleukins IL-4, IL-5 and IL-13, wich locate on different chromosomes, are in close proximity within naive helper T-cells, but after stimulation either into TH1 or TH2 subtypes they move away from each other, so that the genomic region that need to be activated (IFNγ for TH1 or IL-4, IL-5 and IL-13 for TH2) can start gene expression, whereas the region to remain silent is moved to a more repressed region of the nucleus.64
There is increasing evidence suggesting that, in addition to above-mentioned regulation, the higher order chromatin hierarchy has a significant impact in gene regulation. Here insulators, i.e., genomic regions that separate genomic DNA to territories, have an important role.65,66 According to present understanding, enhancer regions within one chromatin loop cannot interact and regulate genes located within other chromatin loops due to the insulators' enhancer blocking activity. In addition, insulators may represent barrier activity meaning that they can block repressive chromatin effects on the adjacent regions.67 The above characteristics of insulators suggest that disappearance of a given insulator may cause defects in gene regulation leading to a serious malfunction of the cell. The TF CTCF and its associated protein cohesin have are important for insulator properties.67 CTCF and cohesin are also involved in the formation of chromatin loops65 suggesting that these proteins may have a role in the dynamic chromatin looping that connects the distant enhancers and gene promoters during transcription.
Biological Impact of Transcriptional Cycling
Although cycling of TFs, their co-regulators and of chromatin markers has been observed with a number of NR target genes,21–23,58,68 not all of them show cycling at mRNA expression level. A requirement for mRNA cycling is that, in addition to TF cycling, the transcript has relatively short half-life. If the transcribed mRNA has longer half-life than the periodicity of binding of the TFs, a stepwise or continuous accumulation of mRNA can be observed (Fig. 1). In addition, in order to observe cycling, mRNA transcription within the cell population must be synchronized. This can be achieved either by pre-treatment with the RNA polymerase II inhibitor α-amanitin21,58 or, in the case of some NR target genes, simply by treating the cells with their ligand.22,69
Figure 1.
Model of transcriptional cycling. Three different levels of mRNA stability are distinguished (inset on top): stable mRNA (solid line, half-live more than 120 min), medium stable mRNA (dashed line, half-life clearly above 60 min) and labile mRNA (pointed line, half-life clearly below 60 min). This results in either steady accumulation of mRNA levels, stair case-type of accumulation or cyclical accumulation (central graph), although in all three cases cyclical TF binding and chromatin looping can be observed (bottom graph).
The reason for cycling may be that it allows more accurate control of the transcription and limits the duration of activation or repression. This is highly important for genes that need to respond quickly to the changes of the environment, such as many NR target genes to their hormonal stimuli. Thus, transcription of these genes appears to have evaluation points, where the need of further mRNA transcription is considered. In cases when the amount of gene product is not sufficient, the next transcriptional cycle is initiated, but when correct levels have been reached, transcription terminates.
Conclusions
In this short review we discussed the impact of the dynamic nature of chromatin organization, i.e., the spatio-temporal changes of chromatin region of NR target genes. This dynamics is triggered by environmental changes, of which in case of NRs the exposure to its natural and synthetic ligands is the most important. For an understanding of skin disorders that involve the actions of NRs this means that the parameter time should be carefully considered in context of other factors that may influence the chromatin organization (and by this the responsiveness) of key NR target genes.
Acknowledgments
Projects on chromatin dynamics of the Väisänen and Carlberg team are supported by the Academy of Finland and the Juselius Foundation.
Abbreviations
- 1,25(OH)2D3
1,25-dihydroxyvitamin D3
- ChIP
chromatin immunoprecipitation
- CoA
co-activator
- CoR
co-repressor
- GR
glucocorticoid receptor
- HAT
histone acetyltransferase
- HDAC
histone deacetylase
- INF
interferon
- LXR
liver X receptor
- MGL
memory gene loop
- NR
nuclear receptor
- PPAR
peroxisome proliferator-activated receptor
- RAR
retinoic acid receptor
- RE
response element
- TF
transcription factor
- TSS
transcription start site
- VDR
vitamin D receptor
References
- 1.Carlberg C, Dunlop TW. The impact of chromatin organization of vitamin D target genes. Anticancer Res. 2006;26:2637–2645. [PubMed] [Google Scholar]
- 2.Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science. 2001;294:1866–1870. doi: 10.1126/science.294.5548.1866. [DOI] [PubMed] [Google Scholar]
- 3.Kim CH. Roles of retinoic acid in induction of immunity and immune tolerance. Endocr Metab Immune Disord Drug Targets. 2008;8:289–294. doi: 10.2174/187153008786848312. [DOI] [PubMed] [Google Scholar]
- 4.Bikle DD. Vitamin D and the skin. J Bone Miner Metab. 2010;28:117–130. doi: 10.1007/s00774-009-0153-8. [DOI] [PubMed] [Google Scholar]
- 5.Baschant U, Tuckermann J. The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol. 2010;120:69–75. doi: 10.1016/j.jsbmb.2010.03.058. [DOI] [PubMed] [Google Scholar]
- 6.Yessoufou A, Wahli W. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels. Swiss Med Wkly. 2010;140:13071. doi: 10.4414/smw.2010.13071. [DOI] [PubMed] [Google Scholar]
- 7.Töröcsik D, Baráth M, Benko S, Széles L, Dezso B, Póliska S, et al. Activation of liver X receptor sensitizes human dendritic cells to inflammatory stimuli. J Immunol. 2010;184:5456–5465. doi: 10.4049/jimmunol.0902399. [DOI] [PubMed] [Google Scholar]
- 8.Thacher SM, Vasudevan J, Chandraratna RA. Therapeutic applications for ligands of retinoid receptors. Curr Pharm Des. 2000;6:25–58. doi: 10.2174/1381612003401415. [DOI] [PubMed] [Google Scholar]
- 9.Winterfield L, Cather J, Cather J, Menter A. Changing paradigms in dermatology: nuclear hormone receptors. Clin Dermatol. 2003;21:447–454. doi: 10.1016/j.clindermatol.2003.08.011. [DOI] [PubMed] [Google Scholar]
- 10.Shahriari M, Kerr PE, Slade K, Grant-Kels JE. Vitamin D and the skin. Clin Dermatol. 2010;28:663–668. doi: 10.1016/j.clindermatol.2010.03.030. [DOI] [PubMed] [Google Scholar]
- 11.Mohan R, Heyman RA. Orphan nuclear receptor modulators. Curr Top Med Chem. 2003;3:1637–1647. doi: 10.2174/1568026033451709. [DOI] [PubMed] [Google Scholar]
- 12.Schweitzer A, Knauer SK, Stauber RH. Nuclear receptors in head and neck cancer: current knowledge and perspectives. Int J Cancer. 2010;126:801–809. doi: 10.1002/ijc.24968. [DOI] [PubMed] [Google Scholar]
- 13.Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835–839. doi: 10.1016/0092-8674(95)90199-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Carlberg C, Polly P. Gene regulation by vitamin D3. Crit Rev Eukaryot Gene Expr. 1998;8:19–42. doi: 10.1615/critreveukargeneexpr.v8.i1.20. [DOI] [PubMed] [Google Scholar]
- 15.Nielsen R, Pedersen TA, Hagenbeek D, Moulos P, Siersbaek R, Megens E, et al. Genome-wide profiling of PPARγ:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev. 2008;22:2953–2967. doi: 10.1101/gad.501108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Welboren WJ, van Driel MA, Janssen-Megens EM, van Heeringen SJ, Sweep FC, Span PN, Stunnenberg HG. ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J. 2009;28:1418–1428. doi: 10.1038/emboj.2009.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Bunger M, Hooiveld GJ, Kersten S, Müller M. Exploration of PPAR functions by microarray technology—a paradigm for nutrigenomics. Biochim Biophys Acta. 2007;1771:1046–1064. doi: 10.1016/j.bbalip.2007.05.004. [DOI] [PubMed] [Google Scholar]
- 18.Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet. 2006;38:1289–1297. doi: 10.1038/ng1901. [DOI] [PubMed] [Google Scholar]
- 19.Farnham PJ. Insights from genomic profiling of transcription factors. Nat Rev Genet. 2009;10:605–616. doi: 10.1038/nrg2636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Turunen M, Dunlop TW, Carlberg C, Väisänen S. Selective use of multiple vitamin D response elements underlies the 1α,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene. Nucleic Acids Res. 2007;35:2734–2747. doi: 10.1093/nar/gkm179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Matilainen JM, Malinen M, Turunen MM, Carlberg C, Väisänen S. The number of active vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells. J Biol Chem. 2010;285:24174–24183. doi: 10.1074/jbc.M110.124073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Saramäki A, Diermeier S, Kellner R, Laitinen H, Väisänen S, Carlberg C. Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1α,25-dihydroxyvitamin D3. J Biol Chem. 2009;284:8073–8082. doi: 10.1074/jbc.M808090200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Makkonen H, Kauhanen M, Paakinaho V, Jääskeläinen T, Palvimo JJ. Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers. Nucleic Acids Res. 2009;37:4135–4148. doi: 10.1093/nar/gkp352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev. 2001;81:1269–1304. doi: 10.1152/physrev.2001.81.3.1269. [DOI] [PubMed] [Google Scholar]
- 25.Burke LJ, Baniahmad A. Co-repressors 2000. FASEB J. 2000;14:1876–1888. doi: 10.1096/fj.99-0943rev. [DOI] [PubMed] [Google Scholar]
- 26.Xu L, Glass CK, Rosenfeld MG. Coactivator and core-pressor complexes in nuclear receptor function. Curr Opin Genet Dev. 1999;9:140–147. doi: 10.1016/S0959-437X(99)80021-5. [DOI] [PubMed] [Google Scholar]
- 27.Moras D, Gronemeyer H. The nuclear receptor ligandbinding domain: structure and function. Curr Opin Cell Biol. 1998;10:384–391. doi: 10.1016/s0955-0674(98)80015-x. [DOI] [PubMed] [Google Scholar]
- 28.Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Gen Dev. 2000;14:121–141. [PubMed] [Google Scholar]
- 29.Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Näär AM, et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature. 1999;398:824–828. doi: 10.1038/19783. [DOI] [PubMed] [Google Scholar]
- 30.Malinen M, Saramäki A, Ropponen A, Degenhardt T, Väisänen S, Carlberg C. Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1α,25-dihydroxyvitamin D3. Nucleic Acids Res. 2008;36:121–132. doi: 10.1093/nar/gkm913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Chen P, Li G. Dynamics of the higher-order structure of chromatin. Protein Cell. 2010;1:967–971. doi: 10.1007/s13238-010-0130-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Li G, Reinberg D. Chromatin higher-order structures and gene regulation. Curr Opin Genet Dev. 2011;21:175–186. doi: 10.1016/j.gde.2011.01.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Saha A, Wittmeyer J, Cairns BR. Chromatin remodelling: the industrial revolution of DNA around histones. Nat Rev Mol Cell Biol. 2006;7:437–447. doi: 10.1038/nrm1945. [DOI] [PubMed] [Google Scholar]
- 34.Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693–705. doi: 10.1016/j.cell.2007.02.005. [DOI] [PubMed] [Google Scholar]
- 35.Hebbes TR, Thorne AW, Crane-Robinson C. A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J. 1998;7:1395–1402. doi: 10.1002/j.1460-2075.1988.tb02956.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Roh TY, Cuddapah S, Zhao K. Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev. 2005;19:542–552. doi: 10.1101/gad.1272505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Kim JK, Samaranayake M, Pradhan S. Epigenetic mechanisms in mammals. Cell Mol Life Sci. 2009;66:596–612. doi: 10.1007/s00018-008-8432-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Hong L, Schroth GP, Matthews HR, Yau P, Bradbury EM. Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 “tail” to DNA. J Biol Chem. 1993;268:305–314. [PubMed] [Google Scholar]
- 39.Bauer WR, Hayes JJ, White JH, Wolffe AP. Nucleosome structural changes due to acetylation. J Mol Biol. 1994;236:685–690. doi: 10.1006/jmbi.1994.1180. [DOI] [PubMed] [Google Scholar]
- 40.Bannister AJ, Kouzarides T. Reversing histone methylation. Nature. 2005;436:1103–1106. doi: 10.1038/nature04048. [DOI] [PubMed] [Google Scholar]
- 41.Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693–705. doi: 10.1016/j.cell.2007.02.005. [DOI] [PubMed] [Google Scholar]
- 42.Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al. High-resolution profiling of his-tone methylations in the human genome. Cell. 2007;129:823–837. doi: 10.1016/j.cell.2007.05.009. [DOI] [PubMed] [Google Scholar]
- 43.Vakoc CR, Sachdeva MM, Wang H, Blobel GA. Profile of histone lysine methylation across transcribed mammalian chromatin. Mol Cell Biol. 2006;26:9185–9195. doi: 10.1128/MCB.01529-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Pokholok DK, Harbison CT, Levine S, Cole M, Hannett NM, Lee TI, et al. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell. 2005;122:517–527. doi: 10.1016/j.cell.2005.06.026. [DOI] [PubMed] [Google Scholar]
- 45.Henikoff S. Nucleosome destabilization in the epigenetic regulation of gene expression. Nat Rev Genet. 2008;9:15–26. doi: 10.1038/nrg2206. [DOI] [PubMed] [Google Scholar]
- 46.Ahmad K, Henikoff S. The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol Cell. 2002;9:1191–1200. doi: 10.1016/s1097-2765(02)00542-7. [DOI] [PubMed] [Google Scholar]
- 47.Farris SD, Rubio ED, Moon JJ, Gombert WM, Nelson BH, Krumm A. Transcription-induced chromatin remodeling at the c-myc gene involves the local exchange of histone H2A.Z. J Biol Chem. 2005;280:25298–25303. doi: 10.1074/jbc.M501784200. [DOI] [PubMed] [Google Scholar]
- 48.Jin C, Felsenfeld G. Nucleosome stability mediated by histone variants H3.3 and H2A.Z. Genes Dev. 2007;21:1519–1529. doi: 10.1101/gad.1547707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Muchardt C, Yaniv MA. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J. 1993;12:4279–4290. doi: 10.1002/j.1460-2075.1993.tb06112.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Zhang B, Chambers KJ, Faller DV, Wang S. Reprogramming of the SWI/SNF complex for co-activation or co-repression in prohibitin-mediated estrogen receptor regulation. Oncogene. 2007;26:7153–7157. doi: 10.1038/sj.onc.1210509. [DOI] [PubMed] [Google Scholar]
- 51.Peterson CL, Tamkun JW. The SWI-SNF complex: a chromatin remodeling machine? Trends Biochem Sci. 1995;20:143–146. doi: 10.1016/s0968-0004(00)88990-2. [DOI] [PubMed] [Google Scholar]
- 52.Agalioti T, Lomvardas S, Parekh B, Yie J, Maniatis T, Thanos D. Ordered recruitment of chromatin modifying and general transcription factors to the IFNβ promoter. Cell. 2000;103:667–678. doi: 10.1016/s0092-8674(00)00169-0. [DOI] [PubMed] [Google Scholar]
- 53.Ramirez-Carrozzi VR, Nazarian AA, Li CC, Gore SL, Sridharan R, Imbalzano AN, Smale ST. Selective and antagonistic functions of SWI/SNF and Mi-2β nucleosome remodeling complexes during an inflammatory response. Genes Dev. 2006;20:282–296. doi: 10.1101/gad.1383206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Hargreaves DC, Horng T, Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell. 2009;138:129–145. doi: 10.1016/j.cell.2009.05.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Ramirez-Carrozzi VR, Braas D, Bhatt DM, Cheng CS, Hong C, Doty KR, et al. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell. 2009;138:114–128. doi: 10.1016/j.cell.2009.04.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Saxonov S, Berg P, Brutlag DL. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci USA. 2006;103:1412–1417. doi: 10.1073/pnas.0510310103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Maston GA, Evans SK, Green MR. Transcriptional regulatory elements in the human genome. Annu Rev Genomics Hum Genet. 2006;7:29–59. doi: 10.1146/annurev.genom.7.080505.115623. [DOI] [PubMed] [Google Scholar]
- 58.Métivier R, Penot G, Hübner MR, Reid G, Brand H, Kos M, Gannon F. Estrogen receptor α directs ordered, cyclical and combinatorial recruitment of cofactors on a natural target promoter. Cell. 2003;115:751–763. doi: 10.1016/s0092-8674(03)00934-6. [DOI] [PubMed] [Google Scholar]
- 59.Pan YF, Wansa KD, Liu MH, Zhao B, Hong SZ, Tan PY, et al. Regulation of estrogen receptor-mediated long range transcription via evolutionary conserved distal response elements. J Biol Chem. 2008;283:32977–32988. doi: 10.1074/jbc.M802024200. [DOI] [PubMed] [Google Scholar]
- 60.Cook PR. Nongenic transcription, gene regulation and action at a distance. J Cell Sci. 2003;116:4483–4491. doi: 10.1242/jcs.00819. [DOI] [PubMed] [Google Scholar]
- 61.Wang Q, Carroll JS, Brown M. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell. 2005;19:631–642. doi: 10.1016/j.molcel.2005.07.018. [DOI] [PubMed] [Google Scholar]
- 62.Nolis IK, McKay DJ, Mantouvalou E, Lomvardas S, Merika M, Thanos D. Transcription factors mediate long-range enhancer-promoter interactions. Proc Natl Acad Sci USA. 2009;106:20222–20227. doi: 10.1073/pnas.0902454106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Tan-Wong SM, Wijayatilake HD, Proudfoot NJ. Gene loops function to maintain transcriptional memory through interaction with the nuclear pore complex. Genes Dev. 2009;23:2610–2624. doi: 10.1101/gad.1823209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Spilianakis CG, Lalioti MD, Town T, Lee GR, Flavell RA. Interchromosomal associations between alternatively expressed loci. Nature. 2005;435:637–645. doi: 10.1038/nature03574. [DOI] [PubMed] [Google Scholar]
- 65.Mishiro T, Ishihara K, Hino S, Tsutsumi S, Aburatani H, Shirahige K, et al. Architectural roles of multiple chromatin insulators at the human apolipoprotein gene cluster. EMBO J. 2009;28:1234–1245. doi: 10.1038/emboj.2009.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Hou C, Zhao H, Tanimoto K, Dean A. CTCF-dependent enhancer-blocking by alternative chromatin loop formation. Proc Natl Acad Sci USA. 2008;105:20398–20403. doi: 10.1073/pnas.0808506106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Wendt KS, Peters JM. How cohesin and CTCF cooperate in regulating gene expression. Chromosome Res. 2009;17:201–214. doi: 10.1007/s10577-008-9017-7. [DOI] [PubMed] [Google Scholar]
- 68.Desvergne B, Héligon C. Steroid hormone pulsing drives cyclic gene expression. Nat Cell Biol. 2009;11:1051–1053. doi: 10.1038/ncb0909-1051. [DOI] [PubMed] [Google Scholar]
- 69.Gynther P, Toropainen S, Matilainen JM, Seuter S, Carlberg C, Väisänen S. Mechanism of 1α,25-dihydroxyvitamin D3 dependent repression of IL-12B. Biochim Biophys Acta Mol Cell Res. 2011;1813:810–818. doi: 10.1016/j.bbamcr.2011.01.037. [DOI] [PubMed] [Google Scholar]